Press releases worldwide
How can we better prepare for future pandemics and health crises? This central question was the focus of the event “Biomedical Preparedness and Health Resilience,” hosted by the Pandemic Alliance Munich (PAM) in collaboration with BioM at the Bavarian Academy […]
As part of this year’s BioEntrepreneur Bootcamp organized by BioM Biotech Cluster GmbH, eleven pre-seed teams took the crucial next step on the path from scientific concept to market-ready application. The training program, which lasted several weeks, culminated in Demo […]
BioM Biotech Cluster Development GmbH and Ludwig-Maximilians-Universität (LMU) Munich have signed a memorandum of understanding to intensify their collaboration. The aim of this partnership is to identify promising research projects with spin-off potential in the fields of life sciences, medicine, […]
The Bavarian biotech cluster organization BioM Biotech Cluster Development GmbH (BioM), the City of Kawasaki, Japan, and the Kawasaki Institute of Industrial Promotion (KIIP) re-signed an expanded memorandum of understanding (MoU) in Munich today. The aim of the cooperation agreement […]
Bavaria’s rising life science entrepreneurs stepped into the spotlight today during the BayStartUP & BioM Pitch Day, connecting high-potential start-ups with leading venture capital investors and business angels. Eight teams from Bavaria’s cutting-edge biotech, digital health, medtech, and diagnostics landscape […]
The Golden Ticket 2025 supported by Daiichi Sankyo for the BioM incubator MAxL has been awarded to RNhale. This award provides the Martinsried-based start-up the opportunity to advance its research on RNA-based therapies for lung diseases free of charge for […]
Biotechnology conference “BayOConnect” in Munich brings together players from all areas of Bavarian and international biotechnology. With around 350 participants, over 350 partnering meetings, 10 start-up pitches and 16 poster presentations, 27 exhibitors and over 40 sponsors and partners, BioM […]
With 2.5 million euros in total funding, the Bavarian m4 Award supports innovative biomedical research projects. The selected research projects deal with the major widespread diseases Alzheimer’s, cancer and rheumatoid arthritis and provide solutions for RNA therapies. The prize money […]
Record financing of over 910 million euros Slight increase to 540 biopharma companies 18 start-ups and new settlements show strong start-up momentum in Bavaria Employment remains stable at 57,000 in the biopharma sector Oncology remains the most important indication in […]
The Japanese pharmaceutical company Daiichi Sankyo has become a “Golden Ticket” sponsor of the BioM incubator MAxL (Munich Accelerator Life Sciences & Medicine). Through this partnership, Daiichi Sankyo specifically supports emerging biotech start-ups thereby making an important contribution to promoting […]